Pfizer Inc said on Friday it signed a multi-year agreement with Gilead Sciences Inc to manufacture and supply the company’s antiviral drug remdesivir for COVID-19 patients.
Pfizer signs deal to manufacture Gilead’s remdesivir for COVID-19
- Advertisement -
Most Popular
Smart money is winning as tariff whiplash, AI grip Wall Street
A noisy, unsettled Wall Street is doing what years of simply owning the index rarely has: made the smart money...
